Document:

EX-4.11

 Exhibit 4.11 

Genius Sports Limited 

(a company limited by shares incorporated under the laws of Guernsey with registered number 

68277 with registered address at 2nd Floor, Trafalgar Court, Les Banques, St Peter Port, 

Guernsey GY1 4LY) 
 STRICTLY PRIVATE AND
CONFIDENTIAL 
 [name] 
 [address] 

2021 
 Dear [●], 

Appointment as Non-Executive Director of Genius Sports Limited (the “Company”) 

We are pleased to confirm your appointment to the board of directors of the Company (the “Board”) as a Class [I / II / III] non-executive director on the terms and subject to the conditions set out below. It is agreed that this is a contract for services and is not a contract of employment for the purposes of the Employment Protection
(Guernsey) Law, 1998 (as amended) or otherwise, and nothing in this letter shall create or be deemed to create an employment relationship between the Company and you. 

Would you please indicate your acceptance of these terms by countersigning a copy of this appointment letter and returning it to the Company. By accepting
this appointment, you confirm that you are not subject to any restrictions which prevent you from holding office as director. 
 Your appointment on the
terms of this letter shall be deemed to take effect on the date of the consummation of the business combination transaction pursuant to that certain Business Combination Agreement, dated as of October 27, 2020, by and among the Company, dMY
Technology Group, Inc. II, a Delaware corporation, and the other parties thereto (the “Business Combination”). In the event that the Business Combination is not consummated, this letter shall automatically terminate and be of no
further force or effect. 
  

	1.	 Appointment and duration 

 

	1.1	 Your appointment is subject to the Companies (Guernsey) Law, 2008 (as amended) (the “Companies
Law”) and the memorandum and articles of incorporation of the Company, as amended from time to time (the “Articles”), and nothing in this letter shall be taken to exclude or vary the terms of the Articles as they apply to
you as a director of the Company. If there is any conflict between the terms of this letter and the Articles, then the Articles shall prevail. 

  

	1.2	 Continuation of your appointment is contingent on your continued satisfactory performance and re-election by the shareholders of the Company as required by the Articles. If the shareholders do not re-elect you as a director in accordance with the Articles, or if your
office is otherwise vacated in accordance with the Articles, your appointment shall terminate automatically and with immediate effect. Notwithstanding any mutual expectation, there is no right to re-nomination
by the Board. You will not have any claim for or based on, loss of office on the expiry of the term of your appointment. 

  

	1.3	 Upon termination of your appointment, you will resign and do everything necessary to assist the Board to effect
your removal as a director and, if applicable, as a director of any of the Company’s subsidiaries. You hereby irrevocably authorise the Company to appoint any other director of the Company in your name and on your behalf to execute any
documents and to do all things required to give effect to such resignation if you fail to do so yourself. 

	1.4	 Upon termination of your appointment, you shall only be entitled to accrued fees as at the date of termination,
together with reimbursement of any expenses properly incurred to that date. 

  

	1.5	 The termination of your appointment (howsoever arising) is without prejudice to the rights, duties and
liabilities of either party accrued prior to termination. The clauses in this appointment letter which expressly or impliedly have effect after termination will continue to be enforceable notwithstanding termination of your appointment.

  

	1.6	 Subject to the duty of confidentiality referred to in clause 7 below and to the Company’s obligations
under the Data Protection Legislation, for so long as any legal claim or regulatory action may lawfully be brought against you in connection with your appointment hereunder, or for a period of seven years following the termination (howsoever
arising) of your appointment hereunder, whichever is the greater, you shall be entitled: 

  

	 	1.6.1	 to retain copies of documents made, compiled or acquired by you during your appointment hereunder, and

  

	 	1.6.2	 on request to the Company secretary, and at the reasonable expense of the Company, to access any documents or
information held or controlled by the Company (in whatever form), where the documents or information are reasonably required by you in connection with actual, threatened or reasonably apprehended legal or regulatory proceedings relating to your
appointment hereunder, which access shall be granted without unreasonable delay. 

  

	2.	 Time Commitment 

 

	2.1	 We expect that the Board will meet regularly. You will also be expected to attend annual and general meetings
and may be appointed to committees of the Board, in which case you will be required to attend committee meetings (further details will be provided in a separate communication setting out the relevant committee’s terms of reference and any
specific responsibilities that may be involved in connection with your appointment to such committee). Your time commitment may increase if you are appointed to any committees of the Board. In addition, you will be expected to consider all relevant
papers prior to each meeting you attend. During your appointment, you will be expected to devote such time as is necessary for the proper performance of your duties. 

 

	2.2	 By accepting this appointment, you confirm that you are able to allocate sufficient time to meet the
expectations of your role and to discharge your responsibilities effectively. The Company should be notified immediately should you form the view that other commitments might affect such ability. The agreement of the Chairman should be sought before
accepting additional commitments, including further directorships of publicly quoted companies, that might affect the time you are able to devote to your position of non-executive director of the Company, or
that might give rise to a conflict of interest. 

  

	2.3	 You should be aware that additional time commitment may be required from you when the Company is undergoing a
period of particularly increased activity. 

  

	3.	 Duties 

  

	3.1	 As a non-executive director, you shall have the same general legal
responsibilities to the Company as any other director. The Board as a whole is collectively responsible for the success of the Company. The Board’s role is to: 

 

	 	3.1.1	 provide effective leadership and control of the Company within a framework of prudent and effective controls
which enable risk to be assessed and managed; 

  
 2 

	 	3.1.2	 set the Company’s objectives, ensure that the necessary financial and management resources are in place
for the Company to meet its objectives and measure performance against them; and 

  

	 	3.1.3	 set the Company’s purpose, values and standards and ensure that its obligations to its shareholders and
others are understood and met. 

  

	3.2	 All directors must act in the way that they consider, in good faith, would be most likely to promote the
success of the Company for the benefit of its members as a whole. In doing so, you will be expected to: 

  

	 	3.2.1	 bring an independent judgment to bear on issues of company strategy, performance, resources (including key
appointments) and standards of conduct, 

  

	 	3.2.2	 faithfully, efficiently, competently and diligently perform your duties and exercise your powers as a non-executive director and carry out all reasonable and lawful directions given by or under the authority of the Board and use your best endeavours to promote and extend the interests and reputation of the Company;
and 

  

	 	3.2.3	 promptly declare, so far as you are aware, the nature of any interest, whether direct or indirect, in any
contract or proposed contract entered into by the Company. 

  

	3.3	 You will be expected to participate in ensuring that the Board exercises effective leadership of and control
over the Company and monitors its business. In particular, you will be expected to bring to the Board knowledge and experience of other business organisations and independence and objectivity of judgement on matters relating to:

  

	 	3.3.1	 the objective and policy of the Company, as well as the principal risks associated with pursuing the strategy
of the Company; 

  

	 	3.3.2	 the Company’s share price performance and net asset value performance, and ways in which future share
price performance might be enhanced; 

  

	 	3.3.3	 the Company’s performance; 

 

	 	3.3.4	 present and future availability and use of resources (you should satisfy yourself that financial information is
accurate and financial controls and systems of risk management are robust and defensible); 

  

	 	3.3.5	 the establishment of a framework of prudent and effective controls which enable risk to be assessed and
managed; and 

  

	 	3.3.6	 standards of conduct, compliance and control in relation to the Board and the Company generally.

  

	3.4	 You will comply where relevant with all applicable legal and regulatory requirements (including where the
Company’s compliance is voluntary), including, and without limitation, every regulation of the New York Stock Exchange and every regulation, code or policy of the Company, including the terms of the insider dealing policy adopted by the Company
in relation to all dealings by you or any person closely associated with you in any securities of the Company. 

  

	3.5	 You are responsible, along with the rest of the Board, for preparing the annual report and accounts of the
Company on the basis set out therein. 

  
 3 

	3.6	 Any communication with or requests for information by press, investors, market analysts or other third parties
should be referred to the Chairman for the time being of the Company. 

  

	3.7	 You will disclose any direct or indirect interest which you may have in any matter being considered at a Board
meeting or committee meeting, and, save as permitted under the Articles, you will not vote on any resolution of the Board, or of one of its committees, on any matter where you have any direct or indirect interest. 

 

	3.8	 You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any
employee or director of which you become aware. 

  

	3.9	 Unless specifically authorised to do so by the Board, you will not enter into any legal or other commitment or
contract on behalf of the Company. 

  

	3.10	 The Company confirms that: 

 

	 	3.10.1	 you will be entitled to full access to all Board papers and accompanying documentation, and should you require
further information at any time, you should contact the company secretary; 

  

	 	3.10.2	 you will be given full access to all information in or about the Company and its affairs which is available to
the directors; 

  

	 	3.10.3	 you are free to question any advisers of the Company; 

 

	 	3.10.4	 you will be advised, where possible, one month in advance of the dates of the meetings of the Board and
meetings of the committees to be attended by you, other than meetings in respect of urgent business which may be called on short notice; 

  

	 	3.10.5	 the agenda for each Board and committee meeting and all relevant and associated papers will normally be
provided to you at least three business days in advance of each meeting; and 

  

	 	3.10.6	 it will endeavour to meet your reasonable requests for the development of your understanding of the environment
within which the Company operates and of its significant relationships with financiers, suppliers, purchasers, share owners and other third parties. You will be entitled at the expense of the Company to travel to meet any such persons if and when
you reasonably determine that to be in the best interests of the Company and in accordance with your duties referred to above. 

  

	4.	 Fees and other benefits 

 

	4.1	 In accordance with the Articles, the Company will reimburse to you all reasonable travelling, hotel and other
expenses properly incurred by you in or about the performance of your duties (including those incurred in attending any meeting of the Board or any committee of the Board or other meeting of the Company), and (subject to you informing the Board in
advance) the taking of reasonable independent legal advice concerning matters relating to your directorship, provided that if and when required by the Company, you will produce to the Company, receipts or other evidence of actual payment of such
expenses. 

  

	4.2	 If you perform any service which in the opinion of the Board goes beyond the ordinary duties of a director
(including serving on any committee of the Board), then you may be paid such additional remuneration as the Board may determine. 

  

	4.3	 You shall bear sole responsibility for payment of any and all foreign, federal, state and local income taxes,
social security taxes and all other taxes (collectively, “Taxes”) related 

  
 4 

	 	
to amounts paid to you hereunder. You understand and agree that, unless otherwise agreed with the Company in writing, you are not eligible for, and you hereby waive any claim to, any benefits
provided to employees of the Company. 

  

	4.4	 You warrant and undertake to the Company that you shall forthwith, on demand, notice or assessment by the
relevant tax authority, pay to such authority any taxes due arising from or in connection with any payment hereunder, and in the event that such demand, notice or assessment is made in the first instance to the Company, you further hereby agree,
undertake and covenant to indemnify the Company and keep the Company indemnified fully against all and any liability to pay any such tax and either (i) to personally pay such tax to the relevant tax authority in settlement of the relevant tax
liability; or (ii) to pay an amount equal to such tax liability to the Company, as the Company shall direct. 

  

	5.	 Independence, other appointments and interests 

 

	5.1	 You will not, during the term of your appointment as a non-executive
director of the Company, without the prior consent of the Board (such consent not to be unreasonably withheld), accept any appointment as a non-executive director of any company with similar objectives to the
Company. 

  

	5.2	 It is accepted and acknowledged that you have business interests other than those of the Company and have
declared any conflicts that are apparent at present. You will ensure that the Board is notified of any changes to such interests and all other companies or partnerships of which you are a director or a partner at any time in order that any statutory
records may be kept properly up to date and any relevant announcements made. You should consult with the Chairman prior to taking on any new board appointments, as the consent of the Board may be required, and promptly notify the Board of any new
board appointments which you take on. 

  

	5.3	 In the event that you become aware of any further potential or actual conflicts of interest, these should be
disclosed to the Board as soon as they become apparent and, again, the agreement of the Board may have to be sought. 

  

	5.4	 In addition, you should notify the Company of and ensure that the Register of Directors’ Interests (if
any) is completed and kept up to date on an ongoing basis in relation to any business or commercial interest which you and your immediate family have which may give rise to any action against, or potential conflict of interest with the interests of,
the Company. These will include details of your private business interests. 

  

	6.	 Professional advice 

If circumstances should arise in which it is necessary for you to seek legal or financial advice in the furtherance of your duties, you should
consult with the Company’s advisers. In such case, the Company will be responsible for your reasonably incurred legal (or other professional) fees. In certain circumstances, you may feel it necessary to take independent professional advice from
advisers other than those of the Company (for example, where you reasonably believe that you have a direct or indirect interest or duty that may conflict with the interests of the Company). The Company will pay directly, or will reimburse to you as
you elect, the full cost of all such advice taken by you in good faith, provided that the Chairman is notified prior to your incurring any such cost. 
  

	7.	 Non-disclosure of Confidential Information

  

	7.1	 In accepting your appointment, you agree not to directly or indirectly divulge or communicate to any person
(other than those of the officials of the Company whose province is to know the same or with the prior written authority of the Company or unless required by law or any regulatory or professional body or save to the extent that such disclosure or
communication is necessary for the proper performance of your duties hereunder or to the extent necessary to disclose the same to your legal advisers in 

  
 5 

	 	
connection with any claims against you or by you regarding or concerning your appointment or to the Company’s insurers in connection with any claim under the Company’s Directors’
and Officers’ Liability Insurance), nor shall you make use of any secret, private or confidential information relating to the affairs of the Company which you may (whether heretofore or hereafter) have received or obtained while a director of
the Company or any information which the Company has obtained from any third party on terms restricting its disclosure or use (“Confidential Information”), and shall use your best endeavours to prevent the publication or disclosure
of the Confidential Information or any part thereof whether relating to its dealings, financial affairs or otherwise which you may have received or obtained or may hereafter receive or obtain while a director of the Company. This restriction shall
continue to apply for a period of twelve (12) months after the termination of your appointment. 

  

	7.2	 You also agree, during the term of your appointment, not to make, otherwise than for the benefit of the
Company, any notes, memoranda, tape recordings, films, photographs, plans, drawings or any form of record relating to any matter within the scope of the business of the Company or concerning any of the dealings or affairs of the Company.

  

	7.3	 The restrictions contained in this clause 7 shall cease to apply to any Confidential Information which may
(otherwise than by reason of your default) become available to the public generally. 

  

	8.	 Indemnity and Insurance 

 

	8.1	 An Indemnification Agreement between you and the Company in the form set out in Schedule 1 to this letter shall
be executed simultaneously with execution of this letter. 

  

	8.2	 The Company will maintain appropriate directors’ and officers’ liability insurance, and it will
maintain such cover for the full term of your appointment. The Company secretary will, on request, supply you with a copy of the terms of such cover. It is also agreed that notwithstanding the termination (for whatever reason) of your appointment,
the Company will use all best endeavours to maintain the directors’ and officers’ liability insurance in respect of you for a period of six (6) years from the date of termination. In the event that the Company is liquidated or
dissolved, the Company shall use its best endeavours to take out ‘run off cover’ for a period of at least three (3) years from the date the Company is liquidated or dissolved. 

 

	8.3	 You undertake to promptly notify the Company secretary if you receive any written claim or demand against you,
or any formal request made to you by a regulatory body (or if you reasonably apprehend that any such claim or demand or formal request will be made), and for which you may or will seek recovery under the Company’s directors’ and
officers’ liability insurance. 

  

	8.4	 The Company shall use reasonable endeavours to procure that the Company secretary, or where the Company
secretary is a company a suitably qualified nominated individual, will be accountable to the Board for notifying the Company’s directors’ and officers’ liability insurers of any circumstance(s) of which that office holder becomes
aware which would likely give rise to a claim against you, and in respect of any claim that is made against you (including any regulatory investigation) in accordance with the policy conditions. 

 

	9.	 Notices 

Any notices to be given hereunder shall, in the case of notices to the Company, be deemed duly served if left at or sent by first class post to
the registered office of the Company, marked for the attention of James Noble, and, in the case of notice to you, if handed to you personally or left at or sent by first class post to your last known address. Any such notice shall be deemed to be
served at the time when the same is handed to or left at the address of the party to be served and if served by post on the day (not being a Sunday or public holiday) next following the day of posting. 

  
 6 

	10.	 Data protection 

 

	10.1	 The Company will hold personal data relating to you for the purposes of complying with applicable laws,
regulations and procedures relating to your non-executive directorship with the Company and to communicate with you. The Company’s processing of your personal information will be carried out in accordance
with the Data Protection (Bailiwick of Guernsey) Law, 2017, and any other applicable data protection legislation (the “Data Protection Legislation”), and the Company’s Privacy Notice, a copy of which will be accessible from the
Company’s website and is available on request by emailing James Noble at james.noble@geniussports.com. 

  

	10.2	 By signing this letter in the space provided below, you acknowledge and agree that: 

 

	 	10.2.1	 you will observe and comply with all data protection, electronic communications, social media policies and
privacy notices adopted and/or amended by the Company from time to time (copies of which will be available on request by emailing James Noble at james.noble@geniussports.com); 

 

	 	10.2.2	 you will observe and comply with the Data Protection Legislation, including, without limitation, where you are
acting as a data controller; and 

  

	 	10.2.3	 you have read, understood and accept the terms of the Privacy Notice. 

 

	11.	 Assignment 

Neither party shall be entitled to assign such party’s rights under this letter without the prior written consent of the other. 

 

	12.	 Third party rights 

No person other than you and the Company shall have any rights under this letter, and the terms of this letter shall not be enforceable by any
person other than you and the Company. 
  

	13.	 Entire agreement 

 

	13.1	 This letter shall be in substitution for all previous letters of appointment between you and the Company which
shall be deemed to have been terminated by mutual consent as from the date on which this letter is deemed to have commenced. 

  

	13.2	 Both you and the Company agree that neither party shall have any remedies in respect of any statement,
representation, assurance or warranty (whether made innocently or negligently) that is not set out in this letter. Each party agrees that such party shall have no claim for innocent or negligent misrepresentation or negligent misstatement based on
any statement in this letter. 

  

	14.	 General 

  

	14.1	 You hereby acknowledge that you have no outstanding claims of any kind against the Company (otherwise than in
respect of director’s fees and other benefits to which you are entitled hereunder accrued due to the date hereof but not yet received). 

  

	14.2	 The parties agree that if any clause or part of any clause of this letter is held to be against the public
interest or unlawful or in any way an unreasonable restraint of trade, the remaining clauses or part of the clause will continue in full force and effect and bind the parties. 

  
 7 

	14.3	 This letter and any dispute arising out of or in connection with it or its subject matter or termination
(including non-contractual disputes or claims) shall be governed and construed in all respects in accordance with the laws of the Island of Guernsey, and each party hereby submits to the non-exclusive jurisdiction of the Royal Court of Guernsey. 

  

	14.4	 This appointment letter may be executed in any number of counterparts and by parties on separate counterparts,
but shall not be effective until such party has executed at least one counterpart. Each counterpart, when executed, shall be an original of this letter, and all counterparts shall together constitute one instrument. 

Please indicate your acceptance of these terms by signing and returning the attached copy of this letter to the Company secretary. 

IN WITNESS of which this document has been duly executed by each of the parties on the day and the year first stated above. 

 

							
	Executed by	 		 		 	
	GENIUS SPORTS LIMITED	 		 		 	
                    

	acting by a director	 		 		 	Director
				
		 		 		 	Print name                                   
                                         
                    
				
	Signed by	 		 		 	
                    

	[●]	 		 		 	Director
				
		 		 		 	Print
name                                        
                                         
               

  
 8 

 SCHEDULE 1 – INDEMNIFICATION AGREEMENT 

  
 9Proof - Test Table.htm

 

Exhibit 10.31

 

 

 

Boingo
Wireless, Inc.

10960 Wilshire Blvd., 23rd Floor

Los Angeles,
CA 90024

 

February 3, 2020

 

Michael J. Zeto III

 

Dear Michael:

 

Boingo Wireless, Inc. (the “Company”)
is pleased to offer you employment on the terms set forth in this letter agreement (the “Agreement”), effective as
of February 24, 2020 (the “Effective Date”).

 

1.                 Position.
Your title and position with the Company will be Senior Vice President, Emerging Business Operations and Strategy, and you will report
directly to the CEO, Mike Finley. This is a full-time position and your place of employment will be our headquarters in Los Angeles.
While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether
full-time or part-time) that would create a conflict of interest with the Company. By signing this Agreement, you confirm to the
Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the
Company.

 

2.                 Cash
Compensation. Beginning on the Effective Date, your annual base salary will be $310,000 per year, payable in accordance with the
Company’s standard payroll schedule. This salary will be subject to adjustment pursuant to the Company’s employee compensation
policies in effect from time to time. In addition, you will be eligible to be considered for a cash-incentive bonus for each fiscal year
of the Company. The bonus (if any) will be awarded based on objective or subjective criteria established and approved by the Compensation
Committee of the Board. Your target bonus will be equal to 55% of your annual base salary, measured as of the last day of each fiscal
year. Any bonus for a fiscal year or quarter will be paid within 21⁄2 months after the close of that fiscal year or quarter, but
only if you are still employed by the Company at the time of payment. The determinations of the Compensation Committee with respect to
your bonus will be final and binding.

 

     

     

    

 

Page 2

 

3.                  Employee Benefits. As a regular employee of the Company, you will be eligible to participate in the Company’s standard
employee benefits programs, as such are in effect from time to time. In addition, you will be entitled to paid vacation in accordance
with the Company’s vacation policy, as in effect from time to time.

 

4.                 
Payments Upon Termination. If your employment with the Company terminates other than as set forth in Section 5 below, then
(a) all vesting will cease immediately with respect to your then-outstanding Equity Awards and (b) the only amounts payable to you by
the Company will be any unpaid base salary due for periods prior to the date of termination of your employment through such termination
date. Such payments, if any, will be made promptly upon termination and within the period of time mandated by law.

 

5.                 Severance
Benefits.

 

(a)               General.
If you are subject to an Involuntary Termination, then you will be entitled to the benefits described in this Section 5. However, you
will not be entitled to any of the benefits described in this Section 5 unless you have (i) returned all Company property in your
possession, (ii) resigned as a member of the Board and of the boards of directors of all of the Company’s subsidiaries, to
the extent applicable, and (iii) executed a general release of all claims that you may have against the Company or persons affiliated
with the Company. The release must be in the form prescribed by the Company, without alterations. You must execute and return the release
on or before the date specified by the Company in the prescribed form (the “Release Deadline”). The Release Deadline
will in no event be later than fifty (50) days after your Separation. If you fail to return the release on or before the Release Deadline,
or if you revoke the release, then you will not be entitled to the benefits described in this Section 5.

 

Notwithstanding
the foregoing, the Company may immediately discontinue all benefits or revoke any vesting acceleration described in this Section 5 (in
addition to pursuing all other legal and equitable remedies) if you breach the Employee Inventions and Confidentiality Agreement or the
Mutual Agreement to Arbitrate Claims between you and the Company that you previously signed (collectively, the “Confidentiality
Agreement”), a copy of which is attached hereto as Exhibit A, the terms of Section 7 below or any other material agreement
with the Company that by its terms continues in force following your Separation.

 

(b)               Termination
Not in Connection With Change in Control. Subject to the requirements set forth in Section 5(a) above, if you experience an Involuntary
Termination either prior to a Change in Control or more than twelve (12) months after a Change in Control, then you will be entitled
to the following:

 

(i)                        Salary
Continuation. The Company will continue to pay your base salary for a period beginning on the day after your Separation and
ending on the date nine (9) months after your Separation. Your base salary will be paid at the rate in effect at the time of your
Separation and in accordance with the Company’s standard payroll procedures. Subject to the Company’s having first
received an effective release pursuant to Section 5(a) above, the salary continuation payments will commence within sixty (60) days
after your Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation. However, if
the sixty (60)-day period described in the preceding sentence spans two calendar years, then the payments will in any event begin in
the second calendar year.

 

     

     

    

 

Page 3

 

(ii)                       
Additional Payment in Lieu of Health Benefit. The Company will pay you a lump sum amount equal to the product of (A) nine
(9) and (B) the monthly amount the Company was paying on behalf of you and your eligible dependents pursuant to the Company’s health
insurance plans in which you or your dependents were participants as of the day of your Separation.  Subject to the Company’s
having first received an effective release pursuant to Section 5(a) above, such payment will be made within sixty (60) days after your
Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in the second calendar year.

 

(iii)                       
Equity Acceleration. You will receive nine (9) months of vesting credit under your then-outstanding Equity Awards; provided,
however, that in the event acceleration of the settlement or distribution date of an award would result in additional taxes and penalties
under Section 409A of the Code, then the vesting of such award shall accelerate but settlement or distribution of award shares (or cash,
if applicable) shall occur on the date(s) specified in the agreement governing the award.

 

(c)              
Termination in Connection With Change in Control. Subject to the requirements set forth in Section 5(a) above, if you experience
an Involuntary Termination within twelve (12) months following a Change in Control, then you will be entitled to the following:

 

(i)                       
Salary Continuation. The Company will continue to pay your base salary for a period beginning on the day after your Separation
and ending on the date twelve (12) months after your Separation. Your base salary will be paid at the rate in effect at the time of your
Separation and in accordance with the Company’s standard payroll procedures. Subject to the Company’s having first received
an effective release pursuant to Section 5(a) above, the salary continuation payments will commence within sixty (60) days after your
Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation. However, if the sixty (60)-day
period described in the preceding sentence spans two calendar years, then the payments will in any event begin in the second calendar
year.

 

(ii)                       
Target Bonus. The Company will pay you a lump sum equal to your annual target bonus in the year of your Separation. Subject
to the Company’s having first received an effective release pursuant to Section 5(a) above, such payment will be made within sixty
(60) days after your Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in the
second calendar year.

 

(iii)                        Additional
Payment in Lieu of Health Benefit. The Company will pay you a lump sum amount equal to the product of (A) twelve (12) and (B)
the monthly amount the Company was paying on behalf of you and your eligible dependents pursuant to the Company’s health
insurance plans in which you or your dependents were participants as of the day of your Separation.  Subject to the
Company’s having first received an effective release pursuant to Section 5(a) above, such payment will be made within sixty
(60) days after your Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in
the second calendar year.

 

     

     

    

 

Page 4

 

(iv)                       
Equity Acceleration. You will receive full vesting credit under your then-outstanding Equity Awards; provided, however,
that in the event acceleration of the settlement or distribution date of an award would result in additional taxes and penalties under
Section 409A of the Code, then the vesting of such award shall accelerate but settlement or distribution of award shares (or cash, if
applicable) shall occur on the date(s) specified in the agreement governing the award.

 

6.                 
Limitation on Payments.

 

(a)              
Scope of Limitation. This Section 6 will apply only if the accounting firm serving as the Company’s independent public
accountants immediately prior to a Change in Control (the “Accounting Firm”) determines that the after-tax value of
all Payments (as defined below) to you under Section 5 of this Agreement, taking into account the effect of all federal, state and local
income taxes, employment taxes and excise taxes applicable to you (including the excise tax under Section 4999 of the Code), will
be greater after the application of this Section 6 than it was before the application of this Section 6. If this Section 6 applies, it
will supersede any contrary provision of this Agreement. For purposes of this Section 6, the term “Company” will also
include affiliated corporations to the extent determined by the Accounting Firm in accordance with Section 280G(d)(5) of the Code.

 

(b)              
Basic Rule. In the event that the Accounting Firm determines that any payment or transfer by the Company to or for your
benefit (a “Payment”) would be nondeductible by the Company for federal income tax purposes because of the provisions
concerning “excess parachute payments” in Section 280G of the Code and pursuant to the regulations thereunder, then provided
that Subsection (a) results in the applicability of this Section 6, the aggregate present value of all Payments will be reduced (but not
below zero) to the Reduced Amount. For purposes of this Section 6, the “Reduced Amount” will be the amount, expressed
as a present value, which maximizes the aggregate present value of the Payments without causing any Payment to be nondeductible by the
Company because of Section 280G of the Code.

 

(c)               Reduction
of Payments. If the Accounting Firm determines that any Payment would be nondeductible by the Company because of
Section 280G of the Code, and if none of the Payments is subject to Section 409A of the Code, then the reduction will occur in
the manner you elect in writing prior to the date of payment; provided, however, that if the manner elected by you pursuant
to this sentence could in the opinion of the Company result in any of the Payments becoming subject to Section 409A of the Code,
then the following sentence will instead apply. If any Payment is subject to Section 409A of the Code, or if you fail to elect an
order under the preceding sentence, then the reduction will occur in the following order: (i) cancellation of acceleration of
vesting of any Equity Awards for which the exercise price (if any) exceeds the then-fair market value of the underlying Stock; (ii)
reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be
made (that is, later payments will be reduced before earlier payments)); and (iii) cancellation of acceleration of vesting of Equity
Awards not covered under (i) above; provided, however, that in the event that acceleration of vesting of Equity Awards is to
be cancelled, such acceleration of vesting will be cancelled in the reverse order of the date of grant of such Equity Awards (that
is, later Equity Awards will be canceled before earlier Equity Awards).

 

     

     

    

 

Page 5

 

(d)              
Fees of Accounting Firm and Required Data. The Company will pay all fees, expenses and other costs associated with retaining
the Accounting Firm for the purposes described in this Section 6. You and the Company will provide to the Accounting Firm all data in
the Company’s possession or under its control that the Accounting Firm reasonably requires for the purposes described in this Section
6.

 

7.                 Further
Obligations to the Company.

 

(a)              
General. You acknowledge your obligations under, and agree to comply with, all applicable laws and all Company policies
in effect at all times and from time to time during your employment with the Company. You further acknowledge and agree that such applicable
laws or policies may relate to the general terms of your employment with the Company or to a specific component of your compensation.
By way of example, such applicable laws or policies may include any Company recoupment or clawback policy, insider trading policy or code(s)
of conduct or other policies adopted under, pursuant to or in light of, or requirements imposed by, the Sarbanes-Oxley Act of 2002 or
the Dodd-Frank Wall Street Reform and Consumer Protection Act.

 

(b)              Confidential
Information. You agree to execute such additional documents as may be necessary to protect the Company’s confidential and proprietary
information, which such documents will supplement the Confidentiality Agreement (which such agreement will continue in full force and
effect).

 

8.                 
Employment Relationship. Employment with the Company is for no specific period of time. Your employment with the Company
remains “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with
or without cause. Any contrary representations that may have been made to you are superseded by this Agreement. This is the full and complete
agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company’s
personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed
in an express written agreement signed by you and a duly authorized officer of the Company (other than you).

 

9.                 
Tax Matters.

 

(a)              
General. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholding
and payroll taxes and other deductions required by law. You are encouraged to obtain your own tax advice regarding your compensation from
the Company. You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities,
and you will not make any claim against the Company or its Board related to tax liabilities arising from your compensation.

 

     

     

    

 

Page 6

 

(b)               Section 409A. For purposes of Section 409A of the Code, each payment under Section 5 is hereby designated as a separate
payment for purposes of Treasury Regulation 1.409A-2(b)(2). If the Company determines that you are a “specified employee”
under Section 409A(a)(2)(B)(i) of the Code at the time of your Separation, then (i) any payments under this Agreement, to the
extent that they are not exempt from Section 409A of the Code (including by operation of the next following sentence) and otherwise
subject to the taxes imposed under Section 409A(a)(1) of the Code (a “Deferred Payment”), will commence on the first
business day following (A) the expiration of the six-month period measured from your Separation or (B) the date of your death and (ii) the
installments that otherwise would have been paid prior to such date will be paid in a lump sum when such payments commence. Notwithstanding
the foregoing, any amount paid under this Agreement that either (1) satisfies the requirements of the “short-term deferral”
rule set forth in Treasury Regulation 1.409A-1(b)(4); or (2) (A) qualifies as a payment made as a result of an involuntary separation
from service pursuant to Treasury Regulation 1.409A-1(b)(9)(iii), and (B) does not exceed the Section 409A Limit will not constitute
a Deferred Payment. The provisions of this Agreement are intended to comply with, or be exempt from, the requirements of Section 409A
of the Code so that none of the payments and benefits to be provided under this Agreement will be subject to the additional tax imposed
under Section 409A of the Code, and any ambiguities herein will be interpreted to so comply or be exempt. You and the Company agree
to work together in good faith to consider amendments to this Agreement and to take such reasonable actions as are necessary, appropriate
or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to you under Section 409A of
the Code. In no event will the Company reimburse you for any taxes that may be imposed on you as result of Section 409A of the Code.

 

10.              
Interpretation, Amendment and Enforcement. Upon the Effective Date, and with the exception of (i) the Confidentiality Agreement
and (ii) the award agreements governing your existing Equity Awards, this Agreement will constitute the complete agreement between you
and the Company, contain all of the terms of your employment with the Company and supersede and replace any prior agreements, policies,
representations or understandings (whether written, oral, implied or otherwise) between you and the Company, including your participation
in the Company’s Severance Benefits Policy. This Agreement may not be amended or modified, except by an express written agreement
signed by both you and a duly authorized officer of the Company. The terms of this Agreement and the resolution of any disputes as to
the meaning, effect, performance or validity of this Agreement or arising out of, related to, or in any way connected with, this Agreement,
your employment with the Company or any other relationship between you and the Company (the “Disputes”) will be governed
by California law, excluding laws relating to conflicts or choice of law. You and the Company submit to the exclusive personal jurisdiction
of the federal and state courts located in California in connection with any Dispute or any claim related to any Dispute. By signing this
Agreement, you acknowledge and agree that you will no longer be eligible for any benefits or payments provided for in any such prior agreement,
except as otherwise expressly provided in this Agreement.

 

11.              
Successors and Assignment.

 

(a)               Company’s
Successors.  Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger,
consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the
obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the
same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this
Agreement, the term “Company” shall include any such successor to the Company, or to the Company’s business and/or
assets, that executes and delivers the assumption agreement described in this Section 11(a) or which becomes bound by the terms
of this Agreement by operation of law.

 

     

     

    

 

Page 7

 

(b)                Employee’s
Successors.  The terms of this Agreement and all of your rights hereunder will inure to the benefit of, and be enforceable by,
your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. All of your
obligations under this Agreement are personal to you and may not be transferred or assigned by you at any time.

 

12.              
Definitions. The following terms have the meaning set forth below wherever they are used in this Agreement:

 

“Board” means
the Company’s Board of Directors.

 

“Cause” means
the occurrence of any one or more of the following: (a) your conviction by, or entry of a plea of “guilty” or nolo
contendere in, a court of competent jurisdiction for any crime which constitutes a felony in the jurisdiction involved, (b) your commission
of an act of theft or fraud, whether prior or subsequent to the date hereof, upon the Company, (c) your gross negligence in the scope
of your services to the Company, (d) your breach of a material provision of any written agreement between you and the Company, (e) your
continuing failure to perform assigned duties after receiving written notification of such failure from the Chief Executive Officer or
(f) your failure to cooperate in good faith with a governmental or internal investigation of the Company or its directors, officers
or employees, if the Company has requested your cooperation.

 

“Change in Control”
means (a) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial
owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than
fifty percent (50%) of the total voting power represented by the Company’s then-outstanding voting securities; (b) the consummation
of the sale or disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger
or consolidation of the Company with or into any other entity, other than a merger or consolidation which would result in the voting securities
of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting
securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; or (d) individuals
who are members of the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the
members of the Board over a period of twelve (12) months; provided, however, that if the appointment or election (or nomination
for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still
in office, such new member shall, for purposes of this Agreement, be considered as a member of the Incumbent Board.

 

     

     

    

 

Page 8

 

A transaction will not constitute
a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that
will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.
In addition, if a Change in Control
constitutes a payment event with respect to any Equity Award which provides for a deferral of compensation and is subject to Section
409A of the Code, then notwithstanding anything to the contrary in this Agreement, the transaction with respect to such Equity Award
must also constitute a “change in control event” as defined in Treasury Regulation 1.409A-3(i)(5) to the extent required
by Section 409A of the Code.

 

“Code” means
the Internal Revenue Code of 1986, as amended.

 

“Equity Awards”
means (a) all shares of Stock; (b) all options and other rights to purchase shares of Stock; (c) all stock units, performance units or
phantom shares whose value is measured by the value of shares of Stock; and (d) all stock appreciation rights whose value is measured
by increases in the value of shares of Stock.

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended.

 

“Involuntary Termination”
means either (a) your Termination Without Cause (other than due to your death or Permanent Disability) or (b) your Resignation for Good
Reason.

 

“Permanent Disability”
means your total and permanent disability as defined in Section 22(e)(3) of the Code.

 

“Resignation for Good
Reason” means a Separation as a result of your resignation within twelve (12) months after one of the following conditions initially
has come into existence without your express written consent:

 

i.                       
A material reduction of your duties, authority and responsibilities, relative to your duties, authority and responsibilities as
in effect immediately prior to such reduction, or the assignment to you of such reduced duties, authority and responsibilities;

 

ii.                       
A reduction in your base salary in effect immediately prior to such reduction;

 

iii.                       
A material reduction in the kind or level of employee benefits to which you were entitled immediately prior to such reduction,
with the result that your overall benefits package is materially reduced;

 

iv.                       
A relocation to a facility or a location more than thirty-five miles from your then-present location that increases your one-way
commute; or

 

v.                       
The Company’s breach of this Agreement, including its failure to obtain the assumption of this Agreement by any successor
(whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the
Company’s business and/or assets.

 

     

     

    

 

Page 9

 

A Resignation for Good Reason will not be deemed
to have occurred unless you give the Company written notice of the condition within ninety (90) days after the condition initially comes
into existence and the Company fails to remedy the condition within thirty (30) days after receiving your written notice.

 

“Section 409A Limit”
means the lesser of two times: (i) your annualized compensation based upon the annual rate of pay paid to you during the taxable
year preceding your taxable year in which your termination of employment occurs, as determined under, and with such adjustments as are
set forth in, Treasury Regulation  1.409A-1(b)(9)(iii)(A)(1) and any guidance issued with respect thereto or (ii) the maximum
amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which your
employment is terminated.

 

“Separation”
means a “separation from service,” as defined in the regulations under Section 409A of the Code.

 

“Stock”
means the Common Stock of the Company.

 

“Termination Without
Cause” means a Separation as a result of a termination of your employment by the Company without Cause, provided you are willing
and able to continue performing services within the meaning of Treasury Regulation 1.409A-1(n)(1).

 

* * * * *

 

     

     

    

 

Page 10

 

You may indicate your agreement
with these terms and accept this offer of continued employment by signing and dating the enclosed duplicate original of this Agreement
and returning it to me.

 

	 	Very truly yours,

 

	 	Boingo Wireless, Inc.

 

	 	By:	/s/ Michael Finley

 

	 	Title: Chief Executive Officer

 

I have read and accept the terms in this Agreement:

 

	/s/ Michael J. Zeto, III	 

Signature of Michael J. Zeto, III

 

	Dated:	2/18/20	 

 

Attachment

 

Exhibit A:      Confidentiality
Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]